Company family · HQ ES
Grifols: medicine shortages
As of 2 Nov 2026, 28 Grifols products have a reported shortage across 3 countries, covering 9 medicines.
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
Open shortages over time
Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Immunoglobulins, Normal Human, for Intravascular Adm. | 11 | 26 Nov 2020 | Increased demand | 6/16 | |
| Albumin | 6 | 20 Apr 2022 | Increased demand | 7/16 | |
| Solvents and Diluting Agents, Incl. Irrigating Solutions | 3 | 6 Jul 2023 | Not stated | 1/16 | |
| Antithrombin III | 2 | 11 Jul 2025 | Manufacturing problem | 2/16 | |
| Hepatitis B Immunoglobulin | 2 | 20 Mar 2026 | Manufacturing problem | 2/16 | |
| Dopamine | 1 | 20 Jul 2020 | Not stated | 2/16 | |
| Fostamatinib | 1 | 22 Jun 2026 | Manufacturing problem | 1/16 | |
| Sodium Bicarbonate | 1 | 13 Nov 2025 | Not stated | 3/16 | |
| Von Willebrand Factor and Coagulation Factor Viii in Combination | 1 | 23 Sep 2026 | Manufacturing problem | 1/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.